Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT05906979 |
Other study ID # |
2023-0615 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 1, 2023 |
Est. completion date |
September 1, 2024 |
Study information
Verified date |
September 2023 |
Source |
Centre for Addiction and Mental Health |
Contact |
Kevin Shield |
Phone |
416-535-8501 |
Email |
kevin.shield[@]camh.ca |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Alcohol use disorders are among the most prevalent mental disorders in Canada; however, due
to numerous barriers, including fear of treatment, privacy concerns, stigma, time conflicts,
and lack of availability of treatment, less than 10% of people with alcohol dependence
receive treatment. Accordingly, there is a need to expand treatment coverage for alcohol use
disorders, especially for populations which face barriers to receiving treatment.
The objective of this proposed project is to develop a digital health worker, named PAHOLA,
which can effectively deliver interventions to people who would not otherwise receive such
treatment. To achieve this objective, the following research aims will be addressed:
1. To develop a digital human-based intervention that can initiate change processes and
reduce alcohol use by applying the principles of motivational interviewing (MI) and
cognitive behavioural therapy (CBT) in a credible manner.
2. To assess the impact of the virtual care provided by PAHOLA on health outcomes using a
randomized controlled study design (RCT) to assess potential effect sizes for a larger
future RCT.
If successful, the PAHOLA project has the potential to transform our ability to prevent
alcohol-attributable harms in Canada by promoting health, health equity, and well-being,
especially among those people who do not normally receive treatment for harmful alcohol use.
Description:
Alcohol use disorders are among the most prevalent mental disorders in Canada; however, due
to numerous barriers, including fear of treatment, privacy concerns, stigma, time conflicts,
and lack of availability of treatment, less than 10% of people with alcohol dependence
receive treatment. Accordingly, there is a need to expand treatment coverage for alcohol use
disorders, especially for populations which face barriers to receiving treatment.
.
The objective of this proposed project is to tailor PAHOLA into a digital health worker which
can effectively deliver BIs to people who would not otherwise receive such treatment. To
achieve this objective, the following research aims will be addressed:
3. To develop a digital human-based intervention that can initiate change processes and
reduce alcohol use by applying the principles of motivational interviewing (MI) and cognitive
behavioural therapy (CBT) in a credible manner.
4. To assess the impact of the virtual care provided by PAHOLA on health outcomes using a
randomized controlled study design (RCT) to assess potential effect sizes for a larger future
RCT.
To address these objectives, the study will employ the following research strategy
This project will build upon the PAHOLA digital human prototype which was developed by Soul
Machines, the Pan American Health Organization (PAHO), and Rooftop to provide information on
alcohol risks and harms. This project will develop PAHOLA to intervene in cases of hazardous
and harmful alcohol use, and will take place in the following three phases:
Phase 1 - development of the intervention dialogue flow program. PAHOLA will (i) screen for
harmful alcohol use using the AUDIT, and (ii) deliver Brief Intervention (BIs). The BIs will
be based primarily on two evidence-based approaches that are used to effectively treat
alcohol misuse, namely MI and CBT. Dialogue will be constructed in alignment with FRAMES -
Feedback, Responsibility, Advice, Menu of options, Empathy, and Self efficacy (confidence for
change),and OARS - (Open ended questions, Affirmation, Reflective listening, and
Summarizing).
Phase 2 - a two-day virtual meeting of researchers, health care providers, and people with
lived experience. A virtual meeting of a total of 30 experts will be held to comment upon and
further develop PAHOLA. Meeting participants will formulate a series of evidence-based
recommendations regarding how to improve: 1) the affinity and trustworthiness of PAHOLA, 2)
the dialogue flow for BIs, and 3) the specific dialogue flows for men and women.
Phase 3 - a pilot randomized controlled trial (RCT) of the PAHOLA intervention program. To
assess PAHOLA as a potential intervention for treating harmful alcohol use, a pilot RCT will
be performed where the first group will receive a BI, the second group will receive a
text-only version of PAHO's BI, and the third group will receive information from PAHOLA
about the risks of alcohol use. A total of 180 adults (18 years of age and older) with
hazardous and harmful alcohol use will be recruited via online advertisements and databases
of individuals interested in participating in research studies.